ArticleInternational journal of molecular sciences2023

Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines.

Marta Sanz-Álvarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.